Table 2.
Meta regression analysis of effect size with respect to region, diagnostic tests, and specie
| Sub-group | Estimate | SE | p-value | CI (95%) |
|---|---|---|---|---|
| Region | ||||
| South Asia (Reference) | ||||
| Africa | 1.3527 | 0.3033 | <.0001 | 1.9496, 0.7558 |
| East Asia and the Pacific | 1.0741 | 0.3601 | 0.0031 | 1.7826, 0.3655 |
| Latin America and the Caribbean | 0.3279 | 0.425 | 0.441 | 1.1643, −0.5085 |
| South America | 1.9233 | 0.562 | 0.0007 | 3.0292, 0.8173 |
| Diagnostic Test | ||||
| Histopathology (Reference) | ||||
| PCR | −0.3059 | 0.6953 | 0.6603 | −1.6742, 1.0624 |
| Microscopy | −0.5356 | 0.6889 | 0.4375 | −1.8913, 0.8201 |
| RDT | −0.6884 | 0.7323 | 0.348 | −2.1296, 0.7528 |
| Specie | ||||
| Plasmodium Vivax (Reference) | ||||
| Plasmodium falciparum | 0.4289 | 0.16 | 0.01 | 0.0945, 0.7632 |
| Plasmodium falciparum and Vivax | −0.8248 | 0.6073 | 0.175 | −2.0199, 0.3703 |